EP0057 is a conjugate of Insert's proprietary drug delivery molecule, Cyclosert, and the potent anti-cancer compound camptothecin.
Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.